{"id":6719,"date":"2022-12-01T17:21:00","date_gmt":"2022-12-01T12:21:00","guid":{"rendered":"https:\/\/www.serenepharma.com\/?p=6719"},"modified":"2023-02-06T17:25:01","modified_gmt":"2023-02-06T12:25:01","slug":"arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir","status":"publish","type":"post","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/","title":{"rendered":"ARNI o\u2019tkir miokard infarkti bo\u2019lgan<br>bemorlarda yurak-qon tomir natijalarini<br>kamaytirishda AAFI\/ARB dan ustundir"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong>Kirish<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo&#8217;lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko&#8217;rsatdi. Shu bilan birga, o&#8217;tkir miokard infarkti (O\u2019MI) bo&#8217;lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to&#8217;g&#8217;risida dalillar etishmasligi mavjud.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Maqsad<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ushbu tadqiqotning maqsadi angiotensin-neprilizin retseptorlari inhibitori (ARNI) terapiyasining samaradorligini angiotensinga aylantiruvchi ferment inhibitori yoki angiotensin retseptorlari blokatori (AAFI\/ARB) bilan o&#8217;tkir miokard infarkti (O\u2019MI) bo&#8217;lgan bemorlarda yurak-qon tomir natijalariga nisbatan solishtirish edi.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Natijalar<\/strong><\/h3>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Birlamchi natijalar<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\"><li>Kombinatsiyalangan natijalarning chastotasi, shu jumladan yurak-qon tomir kasalliklaridan o&#8217;lim, MI, YY va ishemik insult bilan kasalxonaga yotqizish<\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Ikkilamchi natijalar<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\"><li>Yurak-qon tomir kasalliklaridan o&#8217;lim<\/li><li>YY kuchayishi bilan qayta kasalxonaga yotqizish<\/li><li>MI va insultning paydo bo\u2019lishi<\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Keyingi faoliyat<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\"><li>24 oy<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Natijalar<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>O&#8217;rtacha kuzatuv davomiyligi mos ravishda ARNI, AAFI va ARB bilan davolangan bemorlar uchun 9,35, 8,63 va 9,21 oyni tashkil etdi. ARNI, AAFI va ARB bilan davolangan bemorlarning o&#8217;rtacha yoshi mos ravishda 61,82, 61,98 va 62,13 yoshni tashkil etdi.<\/li><li>ARNI bilan davolangan bemorlarda yurak\u2013qon tomir natijalarining kombinatsiyasi AAFI va ARB bilan davolangan bemorlarga qaraganda 49% va 53% past bo&#8217;lgan (XD; 0,47, 95% CI; 0,24-0,90, p=0,02), mos ravishda (1-rasm).<\/li><li>ARNI bilan davolangan bemorlarda yurak\u2013qon tomir kasalliklaridan o&#8217;lim darajasi AAFI (XD; 0,37, 95% CI; 0,18\u20130,79, P=0,01) va ARB (XD; 0,41, 95% CI; 0,18-0,95, P) bilan davolangan bemorlarga qaraganda 63% va 59% past bo&#8217;lgan=0,04), mos ravishda.<\/li><li>Kichik guruh tahliliga ko&#8217;ra, ChQEF \u226440% bo&#8217;lgan bemorlar AAFI [XD; 0,30, 95% CI; 0,11\u20130,86, P=0,01) yoki ARB (XD; 0,21, 95% CI; 0,04\u20131,1, p=0,05) bilan solishtirganda ARNIdan ko&#8217;proq foyda olishdi.<\/li><li>\u226460 yoshdagi bemorlarda kombinatsiyalangan natijalarning kamayishi kuzatildi (ARNI va ARB uchun xavf nisbati; 0,11, 95% CI; 0,03 &#8211; 0,46, P=0,002).<\/li><\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><a href=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/5uz1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/5uz1.jpg\" alt=\"\" class=\"wp-image-6722\" width=\"463\" height=\"351\"\/><\/a><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>Natijalar<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>O\u2019MI bilan og&#8217;rigan bemorlar orasida ARNI yurak-qon tomir tizimining uzoq muddatli salbiy natijalarini kamaytirish nuqtai nazaridan AAFI\/ARB dan ustun edi.<\/li><li>Kichik guruhlar tahlili shuni ko&#8217;rsatdiki, ARNI 40% dan kam va 60 yoshdan kichik bo&#8217;lgan ChQEF bemorlariga ko&#8217;proq foyda keltiradi.<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo&#8217;lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko&#8217;rsatdi. Shu bilan birga, o&#8217;tkir miokard infarkti (O\u2019MI) bo&#8217;lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to&#8217;g&#8217;risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning&#8230;<\/p>\n","protected":false},"author":1,"featured_media":6722,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","inline_featured_image":false,"footnotes":""},"categories":[141],"tags":[160],"class_list":["post-6719","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gazetauz","tag-kardiologiya"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo&#039;lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko&#039;rsatdi. Shu bilan birga, o&#039;tkir miokard infarkti (O\u2019MI) bo&#039;lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to&#039;g&#039;risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"serene_admin\"\/>\n\t<meta name=\"google-site-verification\" content=\"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY\" \/>\n\t<meta name=\"yandex-verification\" content=\"4d7ed8a4cfca7240\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"uz_UZ\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Serene - The Leading Pharmaceutical Company in Central Asia\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene\" \/>\n\t\t<meta property=\"og:description\" content=\"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo&#039;lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko&#039;rsatdi. Shu bilan birga, o&#039;tkir miokard infarkti (O\u2019MI) bo&#039;lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to&#039;g&#039;risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"83\" \/>\n\t\t<meta property=\"og:image:height\" content=\"80\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-12-01T12:21:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-02-06T12:25:01+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Serenepharma\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo&#039;lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko&#039;rsatdi. Shu bilan birga, o&#039;tkir miokard infarkti (O\u2019MI) bo&#039;lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to&#039;g&#039;risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#blogposting\",\"name\":\"ARNI o\\u2019tkir miokard infarkti bo\\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\\\/ARB dan ustundir - Serene\",\"headline\":\"ARNI o\\u2019tkir miokard infarkti bo\\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\\\/ARB dan ustundir\",\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/5uz1.jpg\"},\"datePublished\":\"2022-12-01T17:21:00+05:00\",\"dateModified\":\"2023-02-06T17:25:01+05:00\",\"inLanguage\":\"uz-UZ\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#webpage\"},\"articleSection\":\"Gazeta, Kardiologiya, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"position\":2,\"name\":\"Gazeta\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#listItem\",\"name\":\"ARNI o\\u2019tkir miokard infarkti bo\\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\\\/ARB dan ustundir\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#listItem\",\"position\":3,\"name\":\"ARNI o\\u2019tkir miokard infarkti bo\\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\\\/ARB dan ustundir\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"telephone\":\"+998782910140\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/logo-.png\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#organizationLogo\",\"width\":286,\"height\":120},\"image\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Serenepharma\\\/\",\"https:\\\/\\\/www.instagram.com\\\/serene_group_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/\",\"name\":\"serene_admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"serene_admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#webpage\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/\",\"name\":\"ARNI o\\u2019tkir miokard infarkti bo\\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\\\/ARB dan ustundir - Serene\",\"description\":\"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo'lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko'rsatdi. Shu bilan birga, o'tkir miokard infarkti (O\\u2019MI) bo'lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to'g'risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning\",\"inLanguage\":\"uz-UZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/5uz1.jpg\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#mainImage\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\\\/#mainImage\"},\"datePublished\":\"2022-12-01T17:21:00+05:00\",\"dateModified\":\"2023-02-06T17:25:01+05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"inLanguage\":\"uz-UZ\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene","description":"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo'lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko'rsatdi. Shu bilan birga, o'tkir miokard infarkti (O\u2019MI) bo'lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to'g'risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning","canonical_url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY","yandex-verification":"4d7ed8a4cfca7240","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#blogposting","name":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene","headline":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir","author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/5uz1.jpg"},"datePublished":"2022-12-01T17:21:00+05:00","dateModified":"2023-02-06T17:25:01+05:00","inLanguage":"uz-UZ","mainEntityOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#webpage"},"isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#webpage"},"articleSection":"Gazeta, Kardiologiya, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","position":1,"name":"Home","item":"https:\/\/www.serenepharma.com\/uz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","position":2,"name":"Gazeta","item":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#listItem","name":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#listItem","position":3,"name":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir","previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}}]},{"@type":"Organization","@id":"https:\/\/www.serenepharma.com\/uz\/#organization","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","url":"https:\/\/www.serenepharma.com\/uz\/","telephone":"+998782910140","logo":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/logo-.png","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#organizationLogo","width":286,"height":120},"image":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/Serenepharma\/","https:\/\/www.instagram.com\/serene_group_\/"]},{"@type":"Person","@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author","url":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/","name":"serene_admin","image":{"@type":"ImageObject","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g","width":96,"height":96,"caption":"serene_admin"}},{"@type":"WebPage","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#webpage","url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/","name":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene","description":"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo'lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko'rsatdi. Shu bilan birga, o'tkir miokard infarkti (O\u2019MI) bo'lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to'g'risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning","inLanguage":"uz-UZ","isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/#website"},"breadcrumb":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#breadcrumblist"},"author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"creator":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2023\/02\/5uz1.jpg","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#mainImage"},"primaryImageOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/#mainImage"},"datePublished":"2022-12-01T17:21:00+05:00","dateModified":"2023-02-06T17:25:01+05:00"},{"@type":"WebSite","@id":"https:\/\/www.serenepharma.com\/uz\/#website","url":"https:\/\/www.serenepharma.com\/uz\/","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","inLanguage":"uz-UZ","publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"}}]},"og:locale":"uz_UZ","og:site_name":"Serene - The Leading Pharmaceutical Company in Central Asia","og:type":"article","og:title":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene","og:description":"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo'lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko'rsatdi. Shu bilan birga, o'tkir miokard infarkti (O\u2019MI) bo'lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to'g'risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning","og:url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/","og:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:secure_url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:width":83,"og:image:height":80,"article:published_time":"2022-12-01T12:21:00+00:00","article:modified_time":"2023-02-06T12:25:01+00:00","article:publisher":"https:\/\/www.facebook.com\/Serenepharma\/","twitter:card":"summary","twitter:title":"ARNI o\u2019tkir miokard infarkti bo\u2019lganbemorlarda yurak-qon tomir natijalarinikamaytirishda AAFI\/ARB dan ustundir - Serene","twitter:description":"Kirish Bir nechta klinik tadkikotlar angiotensin-neprilizin retseptorlari inhibitori (ARNI) ning otib berish fraktsiyasi kamaygan yurak etishmovchiligi bo'lgan bemorlarda angiotensinga aylantiruvchi ferment inhibitori (AAFI) yoki angiotensin retseptorlari blokatoridan (ARB) ustunligini ko'rsatdi. Shu bilan birga, o'tkir miokard infarkti (O\u2019MI) bo'lgan bemorlarda ANRIning AAFIga yoki ARB ga nisbatan uzoq muddatli foydalari to'g'risida dalillar etishmasligi mavjud. Maqsad Ushbu tadqiqotning","twitter:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png"},"aioseo_meta_data":{"post_id":"6719","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-02-11 16:37:32","updated":"2026-02-11 16:37:32","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/\" title=\"Gazeta\">Gazeta<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tARNI o\u2019tkir miokard infarkti bo\u2019lgan<br>bemorlarda yurak-qon tomir natijalarini<br>kamaytirishda AAFI\/ARB dan ustundir\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.serenepharma.com\/uz\/"},{"label":"Gazeta","link":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/"},{"label":"ARNI o\u2019tkir miokard infarkti bo\u2019lgan<br>bemorlarda yurak-qon tomir natijalarini<br>kamaytirishda AAFI\/ARB dan ustundir","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/arni-otkir-miokard-infarkti-bolganbemorlarda-yurak-qon-tomir-natijalarinikamaytirishda-aafi-arb-dan-ustundir\/"}],"_links":{"self":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/comments?post=6719"}],"version-history":[{"count":0,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6719\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media\/6722"}],"wp:attachment":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media?parent=6719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/categories?post=6719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/tags?post=6719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}